Maintenance drugs to treat opioid dependence

BMJ (Online)

Volumn 344, Issue 7859, 2012, Pages

  Farrell, Michael ^a   Wodak, Alex ^b   Gowing, Linda ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIRETROVIRUS AGENT; BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; DIAMORPHINE; METHADONE; MORPHINE; OPIATE; OXYCODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; BREAST FEEDING; CONSTIPATION; COST EFFECTIVENESS ANALYSIS; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG OVERDOSE; DRUG SAFETY; HEALTH CARE ORGANIZATION; HUMAN; IMPOTENCE; KIDNEY DISEASE; LIBIDO DISORDER; LIVER DISEASE; MAINTENANCE THERAPY; MORTALITY; OPIATE ADDICTION; PATIENT COMPLIANCE; PATIENT MONITORING; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PRURITUS; PSYCHOSOCIAL CARE; QT INTERVAL; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; SLEEP APNEA SYNDROME; SWEATING; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ADULT; BUPRENORPHINE; FEMALE; HEROIN DEPENDENCE; HUMANS; METHADONE; NARCOTIC ANTAGONISTS; OPIATE SUBSTITUTION TREATMENT;

EID: 84861860465     PISSN: 17561833     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.e2823     Document Type: Article

References (28)

1. Department of Health (England), Scottish Government, Welsh Assembly Government, Northern Ireland Executive. Drug misuse and dependence: UK guidelines on clinical management. 2007. www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-104819.
2. Jaffe JH. Drug addiction and drug abuse. In: Gilman AG, Goodman LS, Gilman A, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 6th ed. Macmillan, 1980:535-84.
3. World Health Organization. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. WHO, 2009. www.who.int/ substance-abuse/publications/opioid-dependence-guidelines.pdf.
4. Strang J, Metrebian N, Lintzeris N, Potts L, Carnwath T, Mayet S, et al. Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial. Lancet 2010;375:1885-95.
5. Farrell M, Hall W. The Swiss heroin trials: testing alternative approaches. BMJ 1998;316:69.
6. Ferri M, Davoli M, Perucci CA. Heroin maintenance for chronic heroin-dependent individuals. Cochrane Database Syst Rev 2010;8:CD003410.
7. Minozzi S, Amato L, Vecchi S, Davoli M, Kirchmayer U, Verster A. Oral naltrexone maintenance treatment for opioid dependence. Cochrane Database Syst Rev 2006;1:CD001333.
8. National Institute for Health and Clinical Excellence. Naltrexone for the management of opioid dependence. (Technology appraisal guidance 115.) 2007. www.nice.org.uk/TA115.
9. National Health and Medical Research Council. Naltrexone implant treatment for opioid dependence. Literature review. 2011. www.nhmrc.gov.au/ files-nhmrc/publications/attachments/ps0005-naltrexone-implant-treatment- literature-review.pdf.
10. Mattick RP, Ali R, White JM, O'Brien S, Wolk S, Danz C. Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients. Addiction 2003;98:441-52. (Pubitemid 36458126)
11. Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2008;16(2):CD002207.
12. Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement for opioid dependence.Cochrane Database Syst Rev 2009;3:CD002209.
13. National Institute for Health and Clinical Excellence. Methadone and buprenorphine for the management of opioid dependence. (Technology appraisal guidance 114.) 2007. www.nice.org.uk/TA114.
14. National Institute for Health and Clinical Excellence. Antenatal and postnatal mental health: clinical management and service guidance. (Clinical guideline 45.) 2007. www.nice.org.uk/CG045.
15. European Monitoring Centre on Drugs and Drug Addiction. Standards and guidelines. 2011. www.emcdda.europa.eu/best-practice/standards/treatment.
16. Amato L, Minozzi S, Davoli M, Vecchi S, Ferri M, Mayet S. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Syst Rev 2008;4:CD004147.
17. Zanis D, Woody G. One-year mortality rates following methadone treatment discharge. Drug and Alcohol Dependence 1998;52:257-60. (Pubitemid 28529584)
18. Cornish R, Macleod J, Strang J, Vickerman P, Hickman M. Risk of death during and after opiate substitute treatment in primary care: prospective observational study in UK general practice research database. BMJ 2010;341:c5475.
19. Bell J, Trinh L, Butler B, Randall D, Rubin G. Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment. Addiction 2009;104:1193-200.
20. Caplehorn JR, Dalton MS, Haldar F, Petrenas AM, Nisbet JG. Methadone maintenance and addicts' risk of fatal heroin overdose. Subst Use Misuse 1996;31:177-96. (Pubitemid 26094982)
21. Anschersen K, Clausen T, Gossop M, Hansteen V, Waal H. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study. Addiction 2009;104:993-9.
22. Burns L, Mattick RP, Lim K, Wallace C(2007)Methadone in pregnancy: treatment retention and neonatal outcomes. Addiction 102:264-70. (Pubitemid 46096288)
23. Minozzi S, Amato L, Vecchi S, Davoli M. Maintenance agonist treatments for opiate dependent pregnant women. Cochrane Database Syst Rev 2008;2:CD006318.
24. Fischer G, Ortner R, Rohrmeister K, Jagsch R, Baewert A, Langer M, et al. Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction 2006;101:275-81. (Pubitemid 43351601)
25. Robertson JR, Raab GM, Bruce M, McKenzie JS, Storkey HR, Salter A. Addressing the efficiency of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: a randomized controlled trial. Addiction 2006;101:1752-9. (Pubitemid 44899697)
26. Jegu J, Gallini A, Soler P, Montastruc J-L, Lapeyre-Mestre M. Slow-release oral morphine for opioid maintenance treatment: a systematic review. Br J Clin Pharmacol 2011;71:832-43.
27. Van den Brink W, Hendricks VM, Blanken P, Koeter MWJ, van Zwieten BJ, van Ree JM. Medical prescription of heroin to treatment resistant heroin addicts: two randomized controlled trials. BMJ 2003;327:310-6.
28. Oviedo-Joekes E, Guh D, Brissette S, Marsh DC, Nosyk B, Krausz M, et al. Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: a pilot study. J Subst Abuse Treat 2010;38:408-11.